Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
AB, acneiform, Asia, Bioscience, composition, compound, concrete, disappointing, disfavor, division, DNA, dry, exceeded, Huddinge, Israel, lethal, linked, methylation, paralog, PDUFA, Philadelphia, PTA, Quotient, reclassified, refractory, repair, serialization, Sharp, shelf, Silencing, Sprint, Sweden, Swedish, synthetic, unfolding, updated, user, Vaccinia
Removed:
eventually, suggest, titled, unconfirmed, uPR
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view